Enhanced Outpatient Symptom Management to Reduce Acute Care Visits Due to Chemotherapy-Related Adverse Events

Conditions:   Clinical Stage IV Esophageal Adenocarcinoma AJCC v8;   Clinical Stage IV Esophageal Squamous Cell Carcinoma AJCC v8;   Clinical Stage IV Gastric Cancer AJCC v8;   Clinical Stage IVA Esophageal Adenocarcinoma AJCC v8;   Clinical Stage IVA Esophageal Squamous Cell Carcinoma AJCC v8;   C linical Stage IVA Gastric Cancer AJCC v8;   Clinical Stage IVB Esophageal Adenocarcinoma AJCC v8;   Clinical Stage IVB Esophageal Squamous Cell Carcinoma AJCC v8;   Clinical Stage IVB Gastric Cancer AJCC v8;   Metastatic Colon Carcinoma;   Metastatic Esophageal Carcinoma;   Met astatic Gastric Carcinoma;   Metastatic Liver Carcinoma;   Metastatic Malignant Digestive System Neoplasm;   Metastatic Malignant Small Intestinal Neoplasm;   Metastatic Malignant Thoracic Neoplasm;   Metastatic Pancreatic Carcinoma;   Metastatic Rectal Carcinoma;   Patholo gic Stage IV Esophageal Adenocarcinoma AJCC v8;   Pathologic Stage IV Esophageal Squamous Cell Carcinoma AJCC v8;   Pathologic Stage IV Gastric Cancer AJCC v8;   Pathologic Stage IVA Esophageal Adenocarcinoma AJCC v8;   Pathologic Stage IVA Esophageal Squamous Cell Carcinoma AJCC v8;   Pa thologic Stage IVB Esophageal Adenocarcinoma AJCC v8;   Pathologic Stage IVB Esophageal Squamous Cell Carcinoma AJCC v8;   Postneoadjuvant Therapy Stage IV Esophageal Adenocarcinoma AJCC v8;   Postneoadjuvant Therapy Stage IV Esophageal Squamous Cell Carcinoma AJCC v8;   Postneoad...
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials